The largest database of trusted experimental protocols

39 protocols using anti cd11c pe

1

Flow Cytometric Analysis of Human and Murine Dendritic Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following Abs were purchased from Becton Dickinson (San Diego, CA, USA; all diluted to 1:50): human phycoerythrin (PE) anti-CD11c, fluorescent isothiocyanate (FITC) anti-major histocompatibility complex (MHC) class II, FITC anti-CD80, FITC anti-CD86, PE anti-IL-3 receptor a chain (CD123), peridinin chlorophyll protein anti-human leukocyte antigen (HLA)-DR, FITC lineage cocktail 1 [lin1, contains monoclonal Abs CD3 (T cells), CD14 (monocytes/macrophages), CD16 (natural killer cells), CD19 (B cells), and CD56 (natural killer cells)], mouse FITC anti-MHC class II, FITC anti-CD80, FITC anti-CD86, and PE anti-CD11c.
Human peripheral blood cells were analyzed by three-color flow cytometry as reported previously24 (link). Human mDCs and pDCs were defined as Lin1HLA-DR+/CD11c+ and Lin1HLA-DR+/CD123+, respectively. Murine splenic DCs were identified as CD11c+ cells and the surface markers were incubated with anti-mouse MHC-II and CD86, respectively. Flow cytometry was performed on a FACS Caliber flow cytometer and analyzed with CellQuest Pro software (Becton Dickinson).
+ Open protocol
+ Expand
2

Intracellular Lin28A Protein Analysis in AML

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cytofluorimetric analysis of intracellular Lin28A protein levels was performed after fixation and permeabilization with the IntraCell Kit (Immunostep, Salamanca, Spain) followed by labeling with Lin28A (Cell Signaling Technology, Danvers, MA, USA) or its isotypic control (Cell Signaling Technology) in 11 BM healthy subjects and 9 AML patients. Lin28A protein expression was also evaluated in myeloid, lymphoid and erythroid precursors of CD34+ cells of healthy subjects by using the following fluorochrome-conjugated monoclonal antibodies and their specific isotypic controls: peridin chlorophyll (PerCP) anti-CD45, phycoerythrin (PE) anti-CD33, PE anti-CD19 and PE anti-CD71 (BD Pharmingen). The expression of myeloid-specific antigens CD14, CD11b and CD15 on cell surface was determined by direct immunofluorescent staining with the following fluorochrome-conjugated monoclonal antibodies and their specific isotypic controls: APC anti-CD14, PE anti-CD11b, PE anti-CD11c and PerCP anti-CD15 (BD Pharmingen). For cell-cycle analysis, cells were fixed and permeabilized, and then labeled with PI/RNase staining solution for 30 min. Cells were acquired by FACS Calibur (BD) and analysis was performed using the ModFit LT Software (Verity Software House, Topsham, ME, USA).
+ Open protocol
+ Expand
3

Analyzing Immune Cells in BALF

Check if the same lab product or an alternative is used in the 5 most similar protocols
After sacrifice, BALF was obtained as previously described (5 (link)). The cells were pelleted and analyzed by flow cytometry using: FITC anti-CD69 (cat# 561929; BD Pharmingen), PerCP anti-CD8a (cat# 45-0081-82; eBioscience), APC anti-CD4 (cat# 100516; BioLegend), PE anti-CD11c (cat#553802, BD Pharmingen), anti-Siglec-H (cat# MCA4647GA, AbD Serotec, Raleigh, NC, USA), APC anti-CD317 (cat# 127015, BioLegend), PerCP anti-CD11b (cat# 101229, BioLegend), FITC anti-rat IgG (cat# 712-095-150, Jackson ImmunoResearch Laboratories). In general, 106 cells were blocked with the anti-FcR mAb 2.4G2, stained with the indicated antibodies for 20 min at 4°C and then washed and resuspended in FACS buffer for analysis. Flow cytometry was performed on a BD FACSCalibur™. Data analysis was performed using BD CellQuest™ Pro software. Cell-free BALF was subjected to cytokine analysis by cytometric bead arrays (CBA) or MPO–DNA complex analysis. The lung was snap frozen in OCT compound and examined for in vivo NET formation.
+ Open protocol
+ Expand
4

T Cell Phenotypic and Functional Analyses

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following reagents and fluorochrome-conjugated monoclonal antibodies were used in this study for T cell phenotypic and functional analyses: PKH26 membrane dye (Sigma), APC- anti-CD4, APC-anti-CD8a, PE-anti-CD4, PE-anti-CD25, FITC or APC-anti-TNFα, PE-anti-ICOS-L FITC-Annexin-V (all from eBioscience), FITC-anti-CXCR4, APC-anti-CXCR7, PE-anti-hCCR4 (all from R&D Systems), and FITC-anti-CD279/PD-1 (Biolegend, San Diego, CA). Intracellular expression of TNFα was detected following fixation and permeabilization (fixation/permeabilization buffer concentrate, Cat. No. 00-5123-43, diluent, Cat. No. 00-5223-56, and permeabilization buffer, Cat. No. 00-8333-56, all from eBioscience). All samples were analyzed with a FACSCalibur flow cytometer, using CellQuest software (BD Biosciences). For analysis of tumor ascites CD14+ cell phenotype, the following monoclonal antibodies were used: FITC-anti-CD14, PE-anti-CD11b (both from R & D Systems), PE-anti-CD11c, PE-anti-B7-H1, PerCP-anti-CD14 (all from BD Biosciences), FITC-anti-CD279/PD-1, FITC-anti-CD83, FITC-anti-CD80, PE-anti-CD86, APC-anti-CD14, and PE-IL-1β (all from eBioscience). Intracellular expression of IL-1β was assayed following overnight incubation of CD14+ cells in the presence of Brefeldin A, followed by fixation and permeabilization as described above.
+ Open protocol
+ Expand
5

Comprehensive Analysis of Schizonepeta Spikelets Phytochemicals

Check if the same lab product or an alternative is used in the 5 most similar protocols
SSP (batch number: 16080053) was obtained from Tongrentang Natural Medicine Co. Ltd. (Beijing, China). The nine major bioactive components of SSP, including deoxyschizandrin (72.6 μg/g), γ-schizandrin (131.5 μg/g), schizandrin (258.0 μg/g), schizandrol B (71.2 μg/g), schisantherin A (25.1 μg/g), psoralen (131.08 μg/g), isopsoralen (1293.7 μg/g), evodiamine (22.2 μg/g), and rutaecarpine (24.0 μg/g), were analyzed by HPLC coupled with ESI-MS/MS (Zhang et al., 2018 (link)). Dextran sodium sulfate (DSS; molecular weight: 36,000–50,000 kD) was obtained from Sigma (St. Louis, MO, USA), and mesalazine (5-ASA; batch number: 170318) was from Sunflower Pharma (Jiamusi, China). Total DNA extraction kit, total RNA extraction kit, First-Stand cDNA reverse transcription kit, polymerase chain reaction kit, and primers were obtained from Shanghai Majorbio Bio-Pharm Technology Co. Ltd. (Shanghai, China). Mouse IL-4, IL-9, IL-17A, and IL-1β ELISA kits were obtained from Thermo Scientific Co. Ltd. (Thermo Fisher, Massachusetts, USA). PE anti-CD11c, AF647 anti-CD103, APC anti-TNF-α, and FITC anti-E-cadherin for flow cytometry were purchased from BD Biosciences (Franklin Lakes, NJ, USA).
+ Open protocol
+ Expand
6

Phagocytosis of Tumor Cells by DCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Neuro-2a and 9464D cells were labeled with 5 mM CellTracker Green CMFDA (Molecular Probes, C7025) for 30 min and then treated with vehicle, NP, cGAMP or STING-NPs for 48 hours. The cells were collected, washed, and co-cultured with BMDCs at a ratio 1:1 for 2 hours.71 (link) The co-cultured cells were harvested, immunostained with PE-anti-CD11c (BD Pharmingen, 550261), dead cells were excluded by SYTOX Blue staining, and, phagocytic efficiency was determined by flow cytometry (BD FACS Verse) and analysis performed using FlowJo (v.10.0.8) software. The phagocytic BMDCs are calculated as the percentage of double-positive CMFDA+CD11c+ cells of all CD11c+ cells (the total BMDC population). Representative flow cytometry dots plots, histograms, and gating strategies for determining tumor cell phagocytosis by DCs are shown in online supplementary figure S9.
+ Open protocol
+ Expand
7

Surface Marker Analysis of Dendritic Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
After 24 h of cell culture, DCs from the five groups were harvested for the anlysis of surface markers expression. The cells were resuspended in PBS containing 1% bovine serum albumin and stained with fluorescently labeled antibodies, including PE-anti-CD11c, FITC-anti-CD86 and Alexa Fluor-anti-MHC-II (all from BD Biosciences, USA) for 30 minutes at 4 °C. Unstained controls were used for the establishment of background fluorescence. The stained cells were analyzed by a flow cytometer (Cytomics TM FC500; Beckman, USA). Data analysis was performed with FlowJo7.6 (Tree Star, Ashland, OR).
+ Open protocol
+ Expand
8

Multiparameter Analysis of Colon Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single cell suspension of colon cells were isolated as previously described [41 (link), 42 (link)] and analyzed by flow cytometry. Cells were stained with the following antibody panels: panel 1) CD45, CD11b, CD11c, F4/80, MHC II, Ly-6C, and Ly-6G; panel 2) CD45, CD11b, CD3, CD4, CD8, CD19, and MHC II. Flow cytometry was performed with the FACS LSR Fortessa (BD Biosciences) and data were analyzed using DIVA software (BD Biosciences). The following antibodies were used: anti-F4/80 BV421 (cat. 565,411), anti-Ly-6C Alexa Fluor 700 (cat. 561,237), anti-CD11c PE (cat. 561,044), anti-MHC II BV650 (cat. 563,415), anti-CD3 BV510 (cat. 563,024) from BD Bioscences (Milano, Italy); anti-CD11b PerCP-Cy5.5 (cat. 45–0112), anti-CD4 Alexa Fluor 700 (cat. 56–0041), anti-Ly-6G FITC (cat. 11–5931), anti-CD45 Pe-Cy5 (cat. 15–0451), anti-CD8 PE (cat. 12–0083), anti-CD19 FITC (cat. 11–0193) from EBiosciences (San Diego, CA, USA).
+ Open protocol
+ Expand
9

Lung Immune Cell Isolation and Flow

Check if the same lab product or an alternative is used in the 5 most similar protocols
The left lobes of the lung tissue were pooled by each group and slightly chopped using a pair of scissors in cold RPMI 1640 containing 1 μg/ml of dipase II (Sigma Aldrich, St. Louis, MO, USA). Samples were incubated at 37°C, 1,100 RPM shaking chamber. After 1 h, samples were placed on 40-μm cell strainer and homogenized using syringe rubber to obtain the single cells. RBCs were lysed using RBC lysis buffer, and flow cytometry assay was performed as previously described (31 (link)). In briefly, cells were stained with anti-CD45-APC (BD Biosciences, San Jose, CA, USA), anti-CD11c-PE (BD Biosciences), and anti-F4/80-FITC (Invitrogen, Carlsbad, CA, USA). Analysis was performed by using MACSQuant Analyzer 10 (Miltenyi Biotec, Bergisch Gladbach, Germany).
+ Open protocol
+ Expand
10

Comprehensive Immune Cell Profiling in Murine Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peritoneal exudate cell (PEC) suspensions were blocked with Fc Block (BD Biosciences, San Jose, CA, USA) and subsequently stained with specific Abs including: anti-Ly6G FITC, anti-CD11cPE, anti-CD11b PerCP/CY5.5, Siglec-F PE, anti-c-kit APC, F4/80 APC, anti-CD4APC, anti-CD19 PerCP/Cy5.5, CD3PE (BD Biosciences, San Jose, CA, USA) and anti-CD206PE or anti-CD206 Alexa fluor 488 (Biolegend, USA). Cells were collected 4 hours after microparticle inoculation for analysis of phosphorylation of BTK (Y-551) or SYK (Y-348). Intracellular staining was performed using anti-mouse phospho-BTK/ITK (Y551/Y511) PE (eBiosciences, San Diego, CA, USA), anti-mouse phospho-SYK (Y-348) PE antibody (BD Biosciences, San Jose, CA, USA) and FOXP3/Transcription Factor Staining Buffer Set, which was used as per the manufacturer instructions (eBiosciences, San Diego,CA, USA). For CFSE-labeled cells, anti-CD4 PerCP (BD Biosciences, San Jose, CA, USA), and KJ1–26 PE (BD Biosciences, San Jose, CA, USA) were used to phenotype DO11.10 T cells and cell cycle progression was examined as previously discussed10 (link). For FACS analysis of whole synovial tissues, samples were digested at 37°C for 1 hour with 0.1% collagenase in RPMI supplemented with 10% FBS, 1000U/ml penicillin, 1000U/ml streptomycin, and 2nm L-glutamine. Single cell suspensions were then prepared and blocked and stained as described above.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!